RxDoctor Payments Data

Rachel Bail, NP

Nurse Practitioner · Athens, OHNPI 1962874941

Payments from drug & device makers

$586in general payments, 2019–2025

Across 29 payments — averaging $20.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$127
  • Exact Sciences$81
  • GSK$67
  • Pfizer$52
  • Astellas Pharma US Inc$51
  • AbbVie$50
  • plus $158 from 7 others

What the payments were for

  • Food & beverage$586100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$586 in reported general payments places this provider in the 80th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$34,768
Medicare patients
167
Services billed
533

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban27$38,559
OzempicSemaglutide33$33,312
JardianceEmpagliflozin21$30,076
XareltoRivaroxaban36$26,634
FarxigaDapagliflozin Propanediol20$18,735
TrulicityDulaglutide12$13,206
LinzessLinaclotide18$12,586
InvokanaCanagliflozin13$8,299
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$7,841
Janumet XrSitagliptin Phos/Metformin Hcl12$4,198
Atorvastatin Calcium397$3,456
Albuterol Sulfate HfaAlbuterol Sulfate63$1,987
Levothyroxine Sodium283$1,936
Celecoxib21$1,565
Pantoprazole Sodium102$1,367

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$52$38,55927 claims
Novo NordiskOzempic$127$33,31233 claims
AbbVieLinzess, Synthroid$50$13,25345 claims
Lilly USA, LLCTrulicity$29$13,20612 claims
GSKTrelegy Ellipta$67$7,84113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Athens

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →